Here are six things to know:
1. Growing obesity levels and advancement in hip reconstruction products are driving market growth.
2. An increasing geriatric population and rising osteoporosis and arthritis cases are fueling market growth.
3. Alternative products and hip reconstruction devices’ escalated costs pose as barriers to market growth.
4. Other factors hindering market growth include skepticism about complications following the procedure, a lack of regulatory standards for global hip reconstruction devices as well as hip implant recalls.
5. North America dominates the market because of reimbursement availability and a large number of aging patients with osteoporosis and arthritis.
6. Market players include Stryker, Smith & Nephew, B. Braun Melsungen, DePuy Synthes, Corin and Zimmer Biomet.
More articles on devices:
29 spine, orthopedic devices receive FDA 510(k) clearance in August
Global spine biologics market to grow at 2% CAGR; Medtronic, J&J among market leaders — 4 highlights
Ortho surgeons to demonstrate HipGrid Drone at conference: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
